American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Microsoft
MSFT
|
+$316M |
| 2 |
Abbott
ABT
|
+$275M |
| 3 |
Lockheed Martin
LMT
|
+$207M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$149M |
| 5 |
Visa
V
|
+$145M |
Top Sells
| 1 |
Occidental Petroleum
OXY
|
+$268M |
| 2 |
Procter & Gamble
PG
|
+$253M |
| 3 |
Dollar Tree
DLTR
|
+$250M |
| 4 |
DXC Technology
DXC
|
+$206M |
| 5 |
General Mills
GIS
|
+$194M |
Sector Composition
| 1 | Financials | 16.32% |
| 2 | Technology | 13.77% |
| 3 | Healthcare | 13.43% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Q2 Holdings
QTWO
$5.13B
| $3.79M | ﹤0.01% |
66,354
-369
| -0.6% | -$21K |
|
|
TAHO
902
DELISTED
Tahoe Resources Inc
TAHO
| $3.78M | ﹤0.01% |
768,000
-137,168
| -15% | -$675K |
|
903
Gold Fields
GFI
$33.7B
| $3.78M | ﹤0.01% |
1,057,400
+513,000
| +94% | +$1.83M |
|
904
Enanta Pharmaceuticals
ENTA
$177M
| $3.76M | ﹤0.01% |
+32,428
| New | +$3.76M |
|
|
MDCO
905
DELISTED
Medicines Co
MDCO
| $3.75M | ﹤0.01% |
+102,157
| New | +$3.75M |
|
|
BPMC
906
DELISTED
Blueprint Medicines
BPMC
| $3.74M | ﹤0.01% |
58,982
+16,197
| +38% | +$1.03M |
|
907
Phibro Animal Health
PAHC
$1.61B
| $3.65M | ﹤0.01% |
79,154
-30,116
| -28% | -$1.39M |
|
908
Pathward Financial
CASH
$1.72B
| $3.61M | ﹤0.01% |
111,276
-3,999
| -3% | -$130K |
|
909
CytomX Therapeutics
CTMX
$330M
| $3.55M | ﹤0.01% |
155,317
-49,743
| -24% | -$1.14M |
|
910
TD Synnex
SNX
$12.5B
| $3.54M | ﹤0.01% |
73,322
-12,640
| -15% | -$610K |
|
911
KB Home
KBH
$4.48B
| $3.53M | ﹤0.01% |
+129,727
| New | +$3.53M |
|
|
SPN
912
DELISTED
Superior Energy Services, Inc.
SPN
| $3.5M | ﹤0.01% |
359,303
| – | – |
|
913
Moog
MOG.A
$6.27B
| $3.48M | ﹤0.01% |
44,620
-29,471
| -40% | -$2.3M |
|
914
AMC Networks
AMCX
$357M
| $3.48M | ﹤0.01% |
55,906
-6,777
| -11% | -$421K |
|
915
Independent Bank Corp
IBCP
$657M
| $3.44M | ﹤0.01% |
135,010
+32,824
| +32% | +$837K |
|
916
Akebia Therapeutics
AKBA
$782M
| $3.44M | ﹤0.01% |
344,447
-156,524
| -31% | -$1.56M |
|
|
TPCO
917
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $3.43M | ﹤0.01% |
198,646
+81,064
| +69% | +$1.4M |
|
|
AAMI
918
Acadian Asset Management Inc.
AAMI
$1.74B
| $3.43M | ﹤0.01% |
240,251
+151,753
| +171% | +$2.16M |
|
919
EverQuote
EVER
$896M
| $3.42M | ﹤0.01% |
+188,934
| New | +$3.42M |
|
|
PENG
920
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.36B
| $3.42M | ﹤0.01% |
+214,818
| New | +$3.42M |
|
921
Williams-Sonoma
WSM
$24B
| $3.41M | ﹤0.01% |
111,208
-47,928
| -30% | -$1.47M |
|
|
CTXS
922
DELISTED
Citrix Systems Inc
CTXS
| $3.41M | ﹤0.01% |
32,547
+1,013
| +3% | +$106K |
|
923
Northwest Bancshares
NWBI
$1.83B
| $3.41M | ﹤0.01% |
196,085
-12,681
| -6% | -$221K |
|
924
Pentair
PNR
$18.2B
| $3.41M | ﹤0.01% |
80,988
+12,659
| +19% | +$533K |
|
|
FLXN
925
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.37M | ﹤0.01% |
130,362
+336
| +0.3% | +$8.69K |
|